| [1] |
Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease：a 10-to 21-year follow-up study of 594 patients[J]. Circulation, 1996, 94(6):1379-1385.
|
| [2] |
Ha KS, Jang G, Lee J, et al. Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis[J]. Eur J Pediatr, 2013, 172(3):343-349.
|
| [3] |
İşgüder R, Doksöz Ö, Bagˇ, Ö, et al. Kawasaki disease shock syndrome: a severe form of Kawasaki disease[J]. Turk J Pediatr, 2013, 55(3):319-321.
|
| [4] |
Kanegaye JT, Wilder MS, Molkara D, et al. Recognition of a Kawasaki disease shock syndrome[J]. Pediatrics, 2009, 123(5):e783-e789.
|
| [5] |
Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association[J]. Pediatrics, 2004, 114(6):1708-1733.
|
| [6] |
Manlhiot C, Christie E, McCrindle BW, et al. Complete and incomplete Kawasaki disease：two sides of the same coin[J]. Eur J Pediatr, 2012, 171(4):657-662.
|
| [7] |
Sonobe T, Kiyosawa N, Tsuchiya K, et al.Prevalence of coronary artery abnormality in incomplete Kawasaki disease[J]. Pediatr Int, 2007, 49(4):421-426.
|
| [8] |
Cimaz R, Sundel R. Atypical and incomplete Kawasaki disease[J]. Best Pract Res Clin Rheumatol, 2009, 23(5):689-697.
|
| [9] |
Chen PS, Chi H, Huang FY, et al. Clinical manifestations of Kawasaki disease shock syndrome：a case-control study[J]. J Microbiol Immunol Infect, 2015, 48(1):43-50.
|
| [10] |
李丰，张园海，邵兰，等．川崎病并发休克6例临床分析[J]．临床儿科杂志，2012，30(10):939-941.
|
| [11] |
Lappin E, Ferguson A. Gram-positive toxic shock syndromes[J]. Lancet Infect Dis, 2009, 9(5):281-290.
|
| [12] |
Gatterre P, Oualha M, Dupic L, et al. Kawasaki disease: an unexpected etiology of shock and multiple organ dysfunction syndrome[J]. Intensive Care Med, 2012, 38(5):872-878.
|
| [13] |
Dominguez SR, Friedman K, Seewald R, et al. Kawasaki disease in a pediatric intensive care unit：a case-control study[J]. Pediatrics, 2008, 122(4): e786-e790.
|
| [14] |
Natterer J, Perez MH, Di Bernardo S. Capillary leak leading to shock in Kawasaki disease without myocardial dysfunction[J]. Cardiol Young, 2012, 22(3):349-352.
|
| [15] |
Onouchi Z, Hamaoka K, Ozawa S, et al. Neutropenia in the acute phase of Kawasaki disease and prevention of coronary artery aneurysm[J]. Pediatr Int, 2009, 51(4):448-452.
|
| [16] |
Lamagni TL, Darenberg J, Luca-Harari B, et al. Epidemiology of severe Streptococcus pyogenes disease in Europe[J]. J Clin Microbiol, 2008, 46(7):2359-2367.
|
| [17] |
Lin YJ, Lin IC, Yu HR, et al. Tricuspid regurgitation in acute phase of Kawasaki disease associated with intensive care unit admission[J]. Pediatr Cardiol, 2013, 34(2):250-255.
|
| [18] |
高戈，冯喆，常志刚，等.2012国际严重脓毒症及脓毒性休克诊疗指南[J]．中华危重病急救医学，2013，25(8):501-505.
|
| [19] |
胡亚美，江载芳．诸福棠实用儿科学.7版[M]．北京：人民卫生出版社，2002：698-705.
|
| [20] |
Baek JY, Song MS.Meta-analysis of factors predicting resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease[J]. Korean J Pediatr, 2016, 59(2):80-90.
|
| [21] |
Sonoda K, Mori M, Hokosaki T, et al.Infliximab plus plasma exchange rescue therapy in Kawasaki disease[J]. J Pediatr, 2014, 164(5):1128-1132.e1.
|